United States Biotechnology & Medical Research

Endocyte Inc (ECYT)

Track

Stock chart
Ticker: ECYT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Andriole Michael T.
Chief Financial Officer
1 sale — total 10,065 USD
Planned sale 9 Oct 2018
Value US$4,334,698.14 | Price 492.21 | Shares 26,922
Planned sale 5 Oct 2018
Value US$3,070,057.20 | Price 455.39 | Shares 13,810
Planned sale 5 Oct 2018
Value US$141,748.03 | Price 15.56 | Shares 9,111
Planned sale 5 Oct 2018
Value US$109,286.90 | Price 15.56 | Shares 7,022
Planned sale 5 Oct 2018
Value US$140,436.86 | Price 15.56 | Shares 9,028
Planned sale 5 Oct 2018
Value US$268,783.49 | Price 15.55 | Shares 17,283
Planned sale 5 Oct 2018
Value US$437,751.92 | Price 15.55 | Shares 28,146
Planned sale 5 Oct 2018
Value US$70,242.81 | Price 15.56 | Shares 4,514
Planned sale 5 Oct 2018
Value US$105,316.13 | Price 15.55 | Shares 6,771
Planned sale 29 Aug 2018
Value US$93,920.00 | Price 20.00 | Shares 4,696
Planned sale 28 Aug 2018
Value US$157,840.00 | Price 20.00 | Shares 7,892
Planned sale 28 Aug 2018
Value US$253,402.53 | Price 20.00 | Shares 12,670
Planned sale 20 Aug 2018
Value US$5,187.03 | Price 18.20 | Shares 285
Planned sale 1 Aug 2018
Value US$22,589.50 | Price 15.98 | Shares 1,414
Planned sale 12 Jun 2018
Value US$197,057.51 | Price 15.06 | Shares 13,089
Planned sale 9 Mar 2018
Value US$45,676.52 | Price 9.07 | Shares 5,036
Sale 28 Dec 2017
Value US$222,824.23 | Price 4.41 | Shares 50,511
Sale 1 Dec 2017
Value US$25,434.33 | Price 5.05 | Shares 5,037
Sale 1 Dec 2017
Value US$91,548.57 | Price 5.03 | Shares 18,194
Buy 13 Nov 2017
Value US$27,104.00 | Price 4.84 | Shares 5,600
Sale 30 Dec 2016
Value US$59,272.20 | Price 2.55 | Shares 23,244
Buy 10 May 2016
Value US$40,040.00 | Price 3.52 | Shares 11,375
Buy 19 Jan 2016
Value US$27,900.00 | Price 2.79 | Shares 10,000
Buy 15 Jan 2016
Value US$56,000.00 | Price 2.80 | Shares 20,000
Sale 3 Mar 2015
Value US$172,986.71 | Price 5.79 | Shares 29,883
Planned sale 11 Aug 2014
Value US$150,353.00 | Price 7.00 | Shares 21,479
Sale 12 Sep 2013
Value US$155,000.00 | Price 15.50 | Shares 10,000
Sale 30 Aug 2013
Value US$86,160.00 | Price 14.36 | Shares 6,000
Sale 6 Aug 2013
Value US$121,030.00 | Price 17.29 | Shares 7,000
Sale 28 May 2013
Value US$1,866.75 | Price 14.25 | Shares 131
Sale 28 May 2013
Value US$22,358.25 | Price 14.25 | Shares 1,569
Sale 24 May 2013
Value US$8,864.10 | Price 14.07 | Shares 630
Sale 24 May 2013
Value US$106,509.90 | Price 14.07 | Shares 7,570
Sale 22 May 2013
Value US$18,117.01 | Price 14.39 | Shares 1,259
Sale 22 May 2013
Value US$217,878.99 | Price 14.39 | Shares 15,141
Sale 21 May 2013
Value US$12,091.95 | Price 14.31 | Shares 845
Sale 21 May 2013
Value US$145,318.05 | Price 14.31 | Shares 10,155
Sale 20 May 2013
Value US$13,944.14 | Price 14.42 | Shares 967
Sale 20 May 2013
Value US$167,747.86 | Price 14.42 | Shares 11,633
Sale 17 May 2013
Value US$249,466.00 | Price 14.42 | Shares 17,300
Sale 17 May 2013
Value US$16,108.77 | Price 14.37 | Shares 1,121
Sale 17 May 2013
Value US$193,693.23 | Price 14.37 | Shares 13,479
Sale 16 May 2013
Value US$25,053.40 | Price 14.44 | Shares 1,735
Sale 16 May 2013
Value US$301,290.60 | Price 14.44 | Shares 20,865
Sale 15 May 2013
Value US$22,164.48 | Price 14.43 | Shares 1,536
Sale 15 May 2013
Value US$266,435.52 | Price 14.43 | Shares 18,464
Sale 14 May 2013
Value US$23,171.94 | Price 14.94 | Shares 1,551
Sale 14 May 2013
Value US$278,616.06 | Price 14.94 | Shares 18,649
Sale 14 May 2013
Value US$73,500.00 | Price 14.70 | Shares 5,000
Planned sale 25 Feb 2013
Value US$19,332.10 | Price 9.70 | Shares 1,993
Planned sale 25 Feb 2013
Value US$1,057.30 | Price 9.70 | Shares 109
Planned sale 19 Feb 2013
Value US$5,015.00 | Price 10.03 | Shares 500
Planned sale 25 Jan 2013
Value US$15,860.04 | Price 9.56 | Shares 1,659
Planned sale 25 Jan 2013
Value US$4,235.08 | Price 9.56 | Shares 443
Planned sale 25 Jan 2013
Value US$1,022.92 | Price 9.56 | Shares 107
Planned sale 26 Dec 2012
Value US$19,023.10 | Price 9.05 | Shares 2,102
Planned sale 26 Dec 2012
Value US$968.35 | Price 9.05 | Shares 107
Planned sale 26 Nov 2012
Value US$16,794.72 | Price 8.72 | Shares 1,926
Planned sale 26 Nov 2012
Value US$2,467.76 | Price 8.72 | Shares 283
Planned sale 25 Oct 2012
Value US$21,449.39 | Price 9.71 | Shares 2,209
Sale 28 Sep 2012
Value US$339,809.60 | Price 9.99 | Shares 34,000
Planned sale 25 Sep 2012
Value US$22,708.74 | Price 10.28 | Shares 2,209
Sale 16 Aug 2012
Value US$96,535.00 | Price 9.65 | Shares 10,000
Sale 6 Jun 2012
Value US$159,674.40 | Price 6.60 | Shares 24,181
Sale 6 Jun 2012
Value US$1,919,704.77 | Price 6.60 | Shares 290,719
Sale 5 Jun 2012
Value US$5,170.07 | Price 6.60 | Shares 783
Sale 5 Jun 2012
Value US$62,179.51 | Price 6.60 | Shares 9,417
Sale 16 May 2012
Value US$14,245.59 | Price 6.65 | Shares 2,142
Sale 16 May 2012
Value US$171,306.15 | Price 6.65 | Shares 25,758
Sale 15 May 2012
Value US$20,510.29 | Price 6.68 | Shares 3,071
Sale 15 May 2012
Value US$246,637.71 | Price 6.68 | Shares 36,929
Sale 14 May 2012
Value US$56,974.31 | Price 6.94 | Shares 8,215
Sale 14 May 2012
Value US$685,113.49 | Price 6.94 | Shares 98,785
Buy 21 Dec 2011
Value US$6,952.00 | Price 3.16 | Shares 2,200
Buy 21 Dec 2011
Value US$688,248.00 | Price 3.16 | Shares 217,800
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-10-09 2018-10-09 PlS Planned sale Andriole Michael T.

Chief Financial Officer

Officer
26,922 +21.2%
492.21
US$4,334,698 		26,922 +21.2% 492.21 US$4,334,698
2018-10-09 2018-10-05 PlS Planned sale Low Philip S

Chief Science Officer

Executive Director
13,810 +25.5%
455.39
US$3,070,057 		13,810 +25.5% 455.39 US$3,070,057
2018-10-09 2018-10-05 PlS Planned sale Armour Alison A.

Chief Medical Officer

Officer
47,560 +48.2%
39.60
US$2,116,211 		47,560 +48.2% 39.60 US$2,116,211
2018-10-09 2018-10-05 PlS Planned sale Taylor Beth

VP Finance & Chief Acctg Offcr

Officer
7,022 -11.1%
15.56
US$109,287 		7,022 -11.1% 15.56 US$109,287
2018-10-09 2018-10-05 PlS Planned sale Leamon Christopher P

Vice President of Research

Officer
9,028 -6.9%
15.56
US$140,437 		9,028 -6.9% 15.56 US$140,437
2018-10-09 2018-10-05 PlS Planned sale Andriole Michael T.

Chief Financial Officer

Officer
17,283 -11.5%
15.55
US$268,783 		17,283 -11.5% 15.55 US$268,783
2018-10-09 2018-10-05 PlS Planned sale Sherman Michael A.

President and CEO

Executive Director
28,146 -7.5%
15.55
US$437,752 		28,146 -7.5% 15.55 US$437,752
2018-10-09 2018-10-05 PlS Planned sale Chelius Erik C.

Vice President CMC

Officer
4,514 -8.3%
15.56
US$70,243 		4,514 -8.3% 15.56 US$70,243
2018-10-09 2018-10-05 PlS Planned sale Parker Katherine

VP of Human Resources

Officer
6,771 -8.8%
15.55
US$105,316 		6,771 -8.8% 15.55 US$105,316
2018-08-29 2018-08-29 PlS Planned sale Leamon Christopher P

Vice President of Research

Officer
4,696 -3.5%
20.00
US$93,920 		4,696 -3.5% 20.00 US$93,920
2018-08-29 2018-08-28 PlS Planned sale Taylor Beth

VP Finance & Chief Acctg Offcr

Officer
7,892 -11.1%
20.00
US$157,840 		7,892 -11.1% 20.00 US$157,840
2018-08-29 2018-08-28 PlS Planned sale Leamon Christopher P

Vice President of Research

Officer
12,670 -8.9%
20.00
US$253,403 		12,670 -8.9% 20.00 US$253,403
2018-08-22 2018-08-20 PlS Planned sale Taylor Beth

VP Finance & Chief Acctg Offcr

Officer
285 -0.4%
18.20
US$5,187 		285 -0.4% 18.20 US$5,187
2018-08-02 2018-08-01 PlS Planned sale Armour Alison A.

Chief Medical Officer

Officer
1,414 -1.3%
15.98
US$22,589 		1,414 -1.3% 15.98 US$22,589
2018-06-13 2018-06-12 PlS Planned sale Leamon Christopher P

Vice President of Research
13,089 -9.1%
15.06
US$197,058 		13,089 -9.1% 15.06 US$197,058
2018-03-12 2018-03-09 PlS Planned sale Leamon Christopher P

Vice President of Research
5,036 -3.4%
9.07
US$45,677 		5,036 -3.4% 9.07 US$45,677
2018-01-02 2017-12-28 S Sale Low Philip S

Chief Science Officer

Executive Director
50,511 -14.3%
4.41
US$222,824 		50,511 -14.3% 4.41 US$222,824
2017-12-04 2017-12-01 S Sale Leamon Christopher P

Vice President of Research
5,037 -3.8%
5.05
US$25,434 		5,037 -3.8% 5.05 US$25,434
2017-12-04 2017-12-01 S Sale Leamon Christopher P

Vice President of Research
18,194 -12.1%
5.03
US$91,549 		18,194 -12.1% 5.03 US$91,549
2017-11-14 2017-11-13 B Purchase Low Philip S

Chief Science Officer

Executive Director
5,600 +2.0%
4.84
US$27,104 		5,600 +2.0% 4.84 US$27,104
2017-01-04 2016-12-30 S Sale Leamon Christopher P

Vice President of Research

Officer
23,244 -25.8%
2.55
US$59,272 		23,244 -25.8% 2.55 US$59,272
2016-05-12 2016-05-10 B Purchase Low Philip S

Chief Science Officer

Executive Director
11,375 +5.5%
3.52
US$40,040 		11,375 +5.5% 3.52 US$40,040
2016-01-20 2016-01-19 B Purchase MIDDLETON FRED A Non-Executive Director
10,000 +5.2%
2.79
US$27,900 		10,000 +5.2% 2.79 US$27,900
2016-01-20 2016-01-15 B Purchase MIDDLETON FRED A Non-Executive Director
20,000 +11.7%
2.80
US$56,000 		20,000 +11.7% 2.80 US$56,000
2015-03-05 2015-03-03 S Sale Nguyen Binh

VP of Medical Affairs

Officer
29,883 -51.3%
5.79
US$172,987 		29,883 -51.3% 5.79 US$172,987
2014-08-13 2014-08-11 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
21,479 -77.5%
7.00
US$150,353 		21,479 -77.5% 7.00 US$150,353
2013-09-16 2013-09-12 S Sale Meek David D.

Chief Commercial Officer

Officer
10,000 -100.0%
15.50
US$155,000 		10,000 -100.0% 15.50 US$155,000
2013-09-04 2013-08-30 S Sale Ritter Allen R

VP of Manufacturing/CMC

Officer
6,000 -25.3%
14.36
US$86,160 		6,000 -25.3% 14.36 US$86,160
2013-08-08 2013-08-06 S Sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
7,000 -100.0%
17.29
US$121,030 		7,000 -100.0% 17.29 US$121,030
2013-05-29 2013-05-28 S Sale HANHAM ANN Non-Executive Director
131 -0.2%
14.25
US$1,867 		131 -0.2% 14.25 US$1,867
2013-05-29 2013-05-28 S Sale HANHAM ANN Non-Executive Director
1,569 -0.2%
14.25
US$22,358 		1,569 -0.2% 14.25 US$22,358
2013-05-29 2013-05-24 S Sale HANHAM ANN Non-Executive Director
630 -1.1%
14.07
US$8,864 		630 -1.1% 14.07 US$8,864
2013-05-29 2013-05-24 S Sale HANHAM ANN Non-Executive Director
7,570 -1.1%
14.07
US$106,510 		7,570 -1.1% 14.07 US$106,510
2013-05-22 2013-05-22 S Sale HANHAM ANN Non-Executive Director
1,259 -2.2%
14.39
US$18,117 		1,259 -2.2% 14.39 US$18,117
2013-05-22 2013-05-22 S Sale HANHAM ANN Non-Executive Director
15,141 -2.2%
14.39
US$217,879 		15,141 -2.2% 14.39 US$217,879
2013-05-22 2013-05-21 S Sale HANHAM ANN Non-Executive Director
845 -1.5%
14.31
US$12,092 		845 -1.5% 14.31 US$12,092
2013-05-22 2013-05-21 S Sale HANHAM ANN Non-Executive Director
10,155 -1.5%
14.31
US$145,318 		10,155 -1.5% 14.31 US$145,318
2013-05-22 2013-05-20 S Sale HANHAM ANN Non-Executive Director
967 -1.7%
14.42
US$13,944 		967 -1.7% 14.42 US$13,944
2013-05-22 2013-05-20 S Sale HANHAM ANN Non-Executive Director
11,633 -1.7%
14.42
US$167,748 		11,633 -1.7% 14.42 US$167,748
2013-05-21 2013-05-17 S Sale Nguyen Binh

VP of Clinical Affairs

Officer
17,300 -100.0%
14.42
US$249,466 		17,300 -100.0% 14.42 US$249,466
2013-05-20 2013-05-17 S Sale HANHAM ANN Non-Executive Director
1,121 -1.9%
14.37
US$16,109 		1,121 -1.9% 14.37 US$16,109
2013-05-20 2013-05-17 S Sale HANHAM ANN Non-Executive Director
13,479 -1.9%
14.37
US$193,693 		13,479 -1.9% 14.37 US$193,693
2013-05-20 2013-05-16 S Sale HANHAM ANN Non-Executive Director
1,735 -2.9%
14.44
US$25,053 		1,735 -2.9% 14.44 US$25,053
2013-05-20 2013-05-16 S Sale HANHAM ANN Non-Executive Director
20,865 -2.9%
14.44
US$301,291 		20,865 -2.9% 14.44 US$301,291
2013-05-16 2013-05-15 S Sale HANHAM ANN Non-Executive Director
1,536 -2.5%
14.43
US$22,164 		1,536 -2.5% 14.43 US$22,164
2013-05-16 2013-05-15 S Sale HANHAM ANN Non-Executive Director
18,464 -2.5%
14.43
US$266,436 		18,464 -2.5% 14.43 US$266,436
2013-05-16 2013-05-14 S Sale HANHAM ANN Non-Executive Director
1,551 -2.4%
14.94
US$23,172 		1,551 -2.4% 14.94 US$23,172
2013-05-16 2013-05-14 S Sale HANHAM ANN Non-Executive Director
18,649 -2.4%
14.94
US$278,616 		18,649 -2.4% 14.94 US$278,616
2013-05-16 2013-05-14 S Sale Leamon Christopher P

Vice President of Research

Officer
5,000 -33.2%
14.70
US$73,500 		5,000 -33.2% 14.70 US$73,500
2013-02-26 2013-02-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
1,993 -100.0%
9.70
US$19,332 		1,993 -100.0% 9.70 US$19,332
2013-02-26 2013-02-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
109 -100.0%
9.70
US$1,057 		109 -100.0% 9.70 US$1,057
2013-02-20 2013-02-19 PlS Planned sale Ritter Allen R

VP of Manufacturing/CMC

Officer
500 -14.4%
10.03
US$5,015 		500 -14.4% 10.03 US$5,015
2013-01-29 2013-01-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
1,659 -100.0%
9.56
US$15,860 		1,659 -100.0% 9.56 US$15,860
2013-01-29 2013-01-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
443 -100.0%
9.56
US$4,235 		443 -100.0% 9.56 US$4,235
2013-01-29 2013-01-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
107 -100.0%
9.56
US$1,023 		107 -100.0% 9.56 US$1,023
2012-12-28 2012-12-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
2,102 -100.0%
9.05
US$19,023 		2,102 -100.0% 9.05 US$19,023
2012-12-28 2012-12-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
107 -100.0%
9.05
US$968 		107 -100.0% 9.05 US$968
2012-11-27 2012-11-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
1,926 -100.0%
8.72
US$16,795 		1,926 -100.0% 8.72 US$16,795
2012-11-27 2012-11-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
283 -100.0%
8.72
US$2,468 		283 -100.0% 8.72 US$2,468
2012-10-29 2012-10-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
2,209 -100.0%
9.71
US$21,449 		2,209 -100.0% 9.71 US$21,449
2012-10-01 2012-09-28 S Sale Low Philip S

Chief Science Officer

Executive Director
34,000 -8.1%
9.99
US$339,810 		34,000 -8.1% 9.99 US$339,810
2012-09-27 2012-09-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
2,209 -100.0%
10.28
US$22,709 		2,209 -100.0% 10.28 US$22,709
2012-08-17 2012-08-16 S Sale Leamon Christopher P

Vice President of Research

Officer
10,000 -39.9%
9.65
US$96,535 		10,000 -39.9% 9.65 US$96,535
2012-06-07 2012-06-06 S Sale HANHAM ANN Non-Executive Director
24,181 -27.4%
6.60
US$159,674 		24,181 -27.4% 6.60 US$159,674
2012-06-07 2012-06-06 S Sale HANHAM ANN Non-Executive Director
290,719 -27.4%
6.60
US$1,919,705 		290,719 -27.4% 6.60 US$1,919,705
2012-06-07 2012-06-05 S Sale HANHAM ANN Non-Executive Director
783 -0.9%
6.60
US$5,170 		783 -0.9% 6.60 US$5,170
2012-06-07 2012-06-05 S Sale HANHAM ANN Non-Executive Director
9,417 -0.9%
6.60
US$62,180 		9,417 -0.9% 6.60 US$62,180
2012-05-18 2012-05-16 S Sale HANHAM ANN Non-Executive Director
2,142 -2.3%
6.65
US$14,246 		2,142 -2.3% 6.65 US$14,246
2012-05-18 2012-05-16 S Sale HANHAM ANN Non-Executive Director
25,758 -2.3%
6.65
US$171,306 		25,758 -2.3% 6.65 US$171,306
2012-05-16 2012-05-15 S Sale HANHAM ANN Non-Executive Director
3,071 -3.3%
6.68
US$20,510 		3,071 -3.3% 6.68 US$20,510
2012-05-16 2012-05-15 S Sale HANHAM ANN Non-Executive Director
36,929 -3.3%
6.68
US$246,638 		36,929 -3.3% 6.68 US$246,638
2012-05-16 2012-05-14 S Sale HANHAM ANN Non-Executive Director
8,215 -8.0%
6.94
US$56,974 		8,215 -8.0% 6.94 US$56,974
2012-05-16 2012-05-14 S Sale HANHAM ANN Non-Executive Director
98,785 -8.0%
6.94
US$685,113 		98,785 -8.0% 6.94 US$685,113
2011-12-22 2011-12-21 B Purchase SANDERLING VENTURES MANAGEMENT V Large shareholder
2,200 +6.7%
3.16
US$6,952 		2,200 +6.7% 3.16 US$6,952
2011-12-22 2011-12-21 B Purchase Sanderling Venture Partners V, LP Large shareholder
217,800 +33.3%
3.16
US$688,248 		217,800 +33.3% 3.16 US$688,248
Explore more

More insider trading research around Endocyte Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America